174 related articles for article (PubMed ID: 14757157)
1. Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs.
Chapman RW; House A; Liu F; Celly C; Mei H; Hey JA
Eur J Pharmacol; 2004 Feb; 485(1-3):329-32. PubMed ID: 14757157
[TBL] [Abstract][Full Text] [Related]
2. Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat.
Bolser DC; DeGennaro FC; O'Reilly S; McLeod RL; Hey JA
Br J Pharmacol; 1997 May; 121(2):165-70. PubMed ID: 9154323
[TBL] [Abstract][Full Text] [Related]
3. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig.
Girard V; Naline E; Vilain P; Emonds-Alt X; Advenier C
Eur Respir J; 1995 Jul; 8(7):1110-4. PubMed ID: 7589394
[TBL] [Abstract][Full Text] [Related]
4. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
5. Emerging targets for cough therapies; NK1 receptor antagonists.
Badri H; Smith JA
Pulm Pharmacol Ther; 2019 Dec; 59():101853. PubMed ID: 31622673
[TBL] [Abstract][Full Text] [Related]
6. Antitussive effect of SR 48968, a non-peptide tachykinin NK2 receptor antagonist.
Advenier C; Girard V; Naline E; Vilain P; Emonds-Alt X
Eur J Pharmacol; 1993 Nov; 250(1):169-71. PubMed ID: 8119316
[TBL] [Abstract][Full Text] [Related]
7. Central regulation of the cough reflex: therapeutic implications.
Canning BJ
Pulm Pharmacol Ther; 2009 Apr; 22(2):75-81. PubMed ID: 19284972
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin receptor antagonists and cough.
Advenier C; Emonds-Alt X
Pulm Pharmacol; 1996; 9(5-6):329-33. PubMed ID: 9232671
[TBL] [Abstract][Full Text] [Related]
9. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
[TBL] [Abstract][Full Text] [Related]
10. The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs.
Lecci A; Giuliani S; Tramontana M; Giorgio RD; Maggi CA
Br J Pharmacol; 1998 May; 124(1):27-34. PubMed ID: 9630339
[TBL] [Abstract][Full Text] [Related]
11. Antitussive action of nociceptin in the cat.
Bolser DC; McLeod RL; Tulshian DB; Hey JA
Eur J Pharmacol; 2001 Oct; 430(1):107-11. PubMed ID: 11698070
[TBL] [Abstract][Full Text] [Related]
12. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist.
Ballard TM; Sänger S; Higgins GA
Eur J Pharmacol; 2001 Feb; 412(3):255-64. PubMed ID: 11166289
[TBL] [Abstract][Full Text] [Related]
14. Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits.
Okano S; Ikeura Y; Inatomi N
J Pharmacol Exp Ther; 2002 Mar; 300(3):925-31. PubMed ID: 11861799
[TBL] [Abstract][Full Text] [Related]
15. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
16. Combined NK(1)and NK(2)receptor antagonists on the bronchoconstrictor response to NKA in dogs.
Chapman RW; Schilling A; Ng K; Nardo C; Kreutner W; Young S
Pulm Pharmacol Ther; 1999; 12(4):261-6. PubMed ID: 10500006
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
Gonsalves S; Watson J; Ashton C
Eur J Pharmacol; 1996 Jun; 305(1-3):181-5. PubMed ID: 8813551
[TBL] [Abstract][Full Text] [Related]
18. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1).
Smith J; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; K Trower M
Chest; 2020 Jan; 157(1):111-118. PubMed ID: 31421110
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough.
McLeod RL; Tulshian DB; Ho GD; Fernandez X; Bolser DC; Parra LE; Zimmer JC; Erickson CH; Fawzi AB; Jayappa H; Lehr C; Erskine J; Smith-Torhan A; Zhang H; Hey JA
Pharmacology; 2009; 84(3):153-61. PubMed ID: 19696521
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
McLean S; Ganong A; Seymour PA; Snider RM; Desai MC; Rosen T; Bryce DK; Longo KP; Reynolds LS; Robinson G
J Pharmacol Exp Ther; 1993 Oct; 267(1):472-9. PubMed ID: 7693914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
